Key Takeaways
- • Intertek Group PLC rejected EQT's third takeover bid, marking a continued rebuff of the Swedish private equity firm's acquisition efforts valued at approximately £9 billion.
- • The board determined the latest offer continues to undervalue the British laboratory testing company while carrying unacceptable execution risk.
- • The rejection signals persistent valuation disagreement between Intertek's management and EQT regarding fair price and deal structure for the global testing, inspection, and certification services provider.
- • Intertek maintains the position that its intrinsic value is not adequately reflected in EQT's proposal, despite the firm's multiple attempts to reach an acceptable offer.
Summary
Intertek Group PLC formally rejected a third takeover proposal from EQT AB, a Swedish private equity firm, on Friday, according to the company's official statement. The rejection underscores an extended negotiation impasse between the two parties, with Intertek's board maintaining that the approximately £9 billion offer fails to appropriately value the British laboratory testing and certification business.
According to Intertek's response, the core issues with EQT's proposal remain twofold: valuation inadequacy and deal risk. The board asserted that the offer continues to undervalue the company relative to its market position and long-term earnings potential. Additionally, the board identified structural risks within EQT's proposal that could jeopardize successful completion of the transaction. These concerns likely encompass financing contingencies, regulatory approval risks, or other closing conditions that the Intertek board views as material threats to deal certainty.
The rejection of a third proposal signals that negotiations between Intertek and EQT have reached an impasse on fundamental commercial terms. Private equity buyers typically increase offer prices incrementally through multiple rounds of bidding, yet Intertek's repeated rejections suggest either that EQT's incremental improvements have been insufficient or that valuation expectations have diverged significantly. For Intertek shareholders, the rejection indicates management confidence in the company's standalone value and willingness to resist EQT's pursuit despite the strategic and financial appeal that private equity acquisition might offer.
The failed bid reflects a broader challenge facing large leveraged buyouts in 2026, where target companies maintain strengthened negotiating positions and sellers increasingly resist offers perceived as undervaluing growth prospects or market dynamics. Intertek's stance signals institutional resistance to discounted takeover multiples and reinforces the pricing discipline among premium-quality industrial service providers in the testing and compliance sector.
According to Intertek's response, the core issues with EQT's proposal remain twofold: valuation inadequacy and deal risk. The board asserted that the offer continues to undervalue the company relative to its market position and long-term earnings potential. Additionally, the board identified structural risks within EQT's proposal that could jeopardize successful completion of the transaction. These concerns likely encompass financing contingencies, regulatory approval risks, or other closing conditions that the Intertek board views as material threats to deal certainty.
The rejection of a third proposal signals that negotiations between Intertek and EQT have reached an impasse on fundamental commercial terms. Private equity buyers typically increase offer prices incrementally through multiple rounds of bidding, yet Intertek's repeated rejections suggest either that EQT's incremental improvements have been insufficient or that valuation expectations have diverged significantly. For Intertek shareholders, the rejection indicates management confidence in the company's standalone value and willingness to resist EQT's pursuit despite the strategic and financial appeal that private equity acquisition might offer.
The failed bid reflects a broader challenge facing large leveraged buyouts in 2026, where target companies maintain strengthened negotiating positions and sellers increasingly resist offers perceived as undervaluing growth prospects or market dynamics. Intertek's stance signals institutional resistance to discounted takeover multiples and reinforces the pricing discipline among premium-quality industrial service providers in the testing and compliance sector.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.